The male god of magic capital

Chapter 161 Chapter 162
"I'll go, this revival medicine is awesome."

"After so many days, I finally made a big move."

"Great news."

"It's been a rough weekend for the shorts of Renaissance Medicine."

"Next Monday, the stock price of Renaissance Medicine will definitely continue to skyrocket."

"Haha, I followed the research report of Chengtian Holdings and bought the shares of Fuxing Medicine."

"Hey, me too. When the research report of Chengtian Holdings came out, I immediately bought it."

"I don't believe in Fang Yi!"

"This Fang Yida Fund is wrong."

"The devil's financial god is still amazing!"

"Fang Yida Medical Fund lost 18 billion in vain!"

"Fang Yida is not optimistic about Fuxing Medicine, but Chengtian Holdings is optimistic about Fuxing Medicine. This time, Chengtian Holdings will win big."

"Yes, Chengtian Holdings can buy 50 billion stocks from Fang Yida Fund, and this time it will make a lot of money."

"This Fang Yida Fund is being taken advantage of."

"Chengtian Private Equity Fund will definitely make a lot of money by investing heavily in Fuxing Medicine this time."

"I don't know how Fang Yida Fund feels."

"I don't know how many shares of Fuxing Medicine are held by Chengtian Private Equity Fund?"

"I heard that I bought a lot before, and together with the 50 billion I bought from Fang Yida, I hold at least 60 billion to 70 billion shares."

"Don't stop!"

"I feel that Chengtian Private Equity Fund has spent at least 80 billion yuan on Fuxing Medicine."

"I'll go, Cheng Tian Private Equity Fund is always full of money, I guess it's 100 billion!"

Now Fuxing Medicine has ushered in a huge turning point, and the fundamentals are improving. This major good news will undoubtedly make the stock price of Fuxing Medicine take off in the next few days.

Moreover, there are a large number of short positions on Renaissance Medicine, and these short positions will be liquidated on a large scale. This means that Renaissance Medicine's stock price will definitely rise sharply next week.

If the stock price of Fuxing Medicine rises sharply, the performance of Chengtian Private Equity Fund will be very good.

If the performance of Chengtian Private Equity Fund is good, then the stock price of Chengtian Holdings will be good.

"I'm going, I'm going to buy the stock of the short holding company at the opening of the market next Monday."

"Yes, the stock price of Chengtian Holdings is still at 9000 yuan per share, which happens to be fully stocked."

"Haha, next Monday, I will fuck Chengtian Holdings, Fuxing Medicine."

"Yes, these two stocks will be aggressively sold next Monday."

"The financial god of Shanghai is the ultimate winner!"

"Although I lost a lot on Chengtian Holdings, this time I am still full of stud Chengtian Holdings."

"Just do it. Last week I made a huge loss on Chengtian Holdings, and next Monday I will have a lot of capital allocation stud!"

'I also plan to allocate capital to Qian Chengtian Holdings, 10 to 100 million, and it's done in one go! '

"Ten times the leverage, allocating 100 million yuan to do it, the profit is 20%, that is 20, and the loss is only 10, do it, do it." A retail investor was very excited.

Now that Fuxing Medicine and Chengtian Holdings are doing well, Luo Cheng is very happy.

The stock price of Tianchengtian Holdings has been sluggish these days, and almost fell below 9000 yuan a share. Fortunately, it has held up. When the market opens next week, the stock price of Chengtian Holdings will skyrocket, needless to say.

The short sellers of Chengtian Holdings will also retreat this time, and it will take minutes for the stock price to return to more than 10000 yuan per share.

It's just a pity that the Chengtian public offering fund has suffered a large number of redemptions, and it will not be able to recover for a while. This is all caused by Tianhai Securities, Jardine Securities, and Lion Securities.

Wu Tianhai also supports Cangshan Group, Kaiyuan Hotel Group, Wangxiangyuan Group, and Tongqinglou Group to set up subsidiaries under Chengtian Holdings. Sooner or later, Luo Cheng will find him to settle accounts.

In the future, support or support their competitors, and then engage them.

Let’s start with the money now. The capital of Chengtian Holdings is still too small. After it grows up, Luocheng Tianhai Group, Jardine Group, and Nuoan Group are simply incomparable. Their listed sub-groups all have a market value of several hundred. [-] million, which is much higher than Chengtian Holding Company!
To them, Chengtian Holdings is still very small. Fortunately, the scale of assets controlled by Chengtian Holdings is very high, and tens of billions of cash can be mobilized at any time.

After Chengtian Holdings grows stronger, it will take revenge on them.

"Next week, the stock prices of Chengtian Holdings and Fuxing Pharmaceutical will rise sharply. The short side will not be able to sleep well this week."

At this time, Jiang Manman walked in and said, "Boss, Fang Yida Fund approached him and said that he would buy back the Fuxing Pharmaceutical stock that was sold to us before."

Luo Cheng was taken aback, Fang Yida was rich and powerful, with assets exceeding 2 trillion yuan, so he was going to buy Fuxing Medicine again soon?

I heard that Fang Yida Medical Fund bought Fuxing Medicine's competitor, Shenzhou Baekje Biological Company, but I didn't expect to come back to buy Fuxing Medicine in a blink of an eye.

"What price are they going to give?" Luo Cheng asked.

Before, Chengtian Private Equity Fund bought 55 billion shares of Fuxing Medicine in the hands of Fang Yida Fund at a price of 50 yuan per share. If you want to buy it back now, it is not 55 yuan per share.

This Friday, the stock price of Fuxing Medicine soared to 60 yuan per share in late trading, and it will continue to soar at the opening of next Monday. Fang Yida must pay a premium if he wants to buy it back.

Jiang Manman said: "They plan to buy it back at a price of 16.66 yuan per share at a premium of 70."

Previously, Fang Yida sold 55 million shares to Chengtian Private Equity Fund at a price of 9090 yuan per share, but now he bought them back at a price of 70 yuan per share, which is a huge loss.

But Luo Cheng refused.

"The premium is too low, let's see how much Fuxing Pharmaceutical's stock price rises next week!"

"Yes, BOSS." Jiang Manman politely rejected Fang Yida Fund immediately.

In the evening, Luo Cheng, Zhang Hanlin, Zhou Yuanping, and Ling Guangchang gathered by the Huangpu River.

Eating the crabapple cake, it is brown in shape, sprinkled with caramel sugar on the surface, and has a very sweet taste.

"Did Fang Yida contact you this time?" Luo Cheng asked.

"I have contacted, 70 yuan a share, I did not agree." Zhou Yuanping said with a smile.

"I didn't agree either. Next Monday, the stock price of Review Medicine may go up to the limit." Zhang Hanlin was a little excited.

"With so many short positions to be liquidated, plus the good news, it is normal for Fuxing Pharmaceutical's stock price to reach 80 yuan per share." Ling Guangchang was also very excited.

"The stock price of Fuxing Pharmaceutical is definitely going to hit a new high." Luo Cheng smiled and said: "Fang Yida is starting to be optimistic about its prospects, and would rather buy it back at 70 yuan a share, which shows that they are at least optimistic that the stock price of Fuxing Pharmaceutical will rise to More than 90 yuan per share."

"Wait until next week!"

Time flies, and on February 2th, when the stock market opened on Monday, the stock price of Renaissance Medicine soared, and the short sellers also liquidated their positions on a large scale.

61.78
62.77
63.11
64.45
65.98
···
The position of 70.00, the closing price in the morning, has returned to the position of 70 yuan per share, which is quite scary!
It's not over yet, when the market opened in the afternoon, Fuxing Medicine's stock price continued to rise!
A large number of retail investors and institutional traders entered the market to buy, and the previous short sellers also closed their positions frantically, which continued to push up the stock price.

71.55
72.11
73.99
74.20
···
78.00 position, daily limit!
It turned out that the daily limit was reached, which was something Luo Cheng did not expect.

Previously, the highest stock price of Fuxing Medical was 77 yuan per share, but now it has reached 78 yuan per share, which has reached a record high.

The bull side is very strong!
The average price of opening a position of Chengtian Private Equity Fund is at 55.00, which has a floating profit of 41.81%, which is calculated as a floating profit of 41.81 billion.

Harvest abundantly!

The soaring stock price of Fuxing Medicine today also let investors see that the performance of Chengtian Private Equity Fund has taken off. A large number of investors bought the shares of Chengtian Holding Company, and the short sellers also frantically closed their positions.

The stock price of Chengtian Holdings also skyrocketed!
9135
9246
9345
9488
9544
···
10000 yuan per share, without any stop, continue to skyrocket!
It rushed to 11000 yuan per share, and at the close, the market value returned to 110 billion.

As for the Hong Kong stock market, the stock price of Fuxing Medicine in Hong Kong stocks rushed to 35 yuan per share. The Roche Family Foundation held 2500 million shares, and the average price of opening positions was 20 Hong Kong dollars per share.

It's a pity that the stock price of A-share Ogilvy Medicine only rose by 1 yuan to 37 yuan per share. The Roche Family Foundation holds 1200 million shares. Now it has a floating profit of 12 yuan per share, a total floating profit of 1.44 million, and a net account value of 4.44 million. Ogilvy's share price hit another record high, yes, yes.

And Fang Yida Fund contacted Chengtian Holding Company again, saying that it bought all the shares of Fuxing Medicine held by Chengtian Private Equity at the market price.

Buy all the shares of Fuxing Medicine held by Chengtian Private Equity Fund at the market price?
The current value is 141.81 billion. If it is sold to Fang Yida Fund at the market price now, the profit will be 41.81 billion, with a 20% commission, which is more than 8 million. This is undoubtedly a great performance. The stock price of Chengtian Holdings will continue to skyrocket , back to 130 billion!
Luo Cheng thought for a while and said, "Keep waiting, don't worry!"

"Yes, BOSS." Jiang Manman immediately replied to Fang Yida Fund, and the other party continued to say that it would be purchased at a premium, offering a price of 80 yuan per share.

"BISSS, Fang Yida Fund offers 80 yuan a share, shall we agree?" Jiang Manman said excitedly.

Luo Cheng shook his head: "Don't worry, if you wait any longer, the stock price of Fuxing Medicine can still rise. Fang Yida can give us 80 yuan a share, which shows that they are more optimistic about Fuxing Medicine's stock price than us, so don't worry!"

The next day, Tuesday, June 2, the stock market opened.

Fuxing Pharmaceutical's share price continues to soar!
78.84
79.44
The 80.00 position encountered resistance temporarily, and continued to rise after 10:[-] am!
81.15,

82.77,

···
In the end, it reached 88 yuan per share, and then the market closed. Chengtian Private Equity Fund had a huge floating profit on its books!
Floating profit 60%, 60 billion!

The net value of the account is as high as 160 billion!
Luo Cheng immediately said to Jiang Manman: "Contact Fang Yida Fund immediately, the market price can be sold to them, and see if they are interested in accepting it at a price of 88 yuan per share. If not, we will continue hold!"

Although the stock price of Fuxing Medicine will rise in the future, if Chengtian Private Equity Fund closes its positions, the stock price will plummet. It is still unknown whether the average position of closing positions will be at 88 yuan per share. After all, 160 billion worth of stocks are sold. Go out, I don't know where the stock price of Fuxing Medicine will fall! .

Jiang Manman immediately contacted Fang Yida Fund, and the other party asked for a discount, and the price was 85 yuan per share, but Luo Cheng disagreed, and the price was 88 yuan per share.

"Tell them that the stock price of Fuxing Medicine will continue to rise. If they don't buy it, we will dismantle it and sell it to other institutions."

"Yes, boss!"

The other party bargained unsuccessfully for many times, and finally decided to buy all the shares of Fuxing Medicine held by Chengtian Private Equity Fund at a price of 88 yuan per share!
Worth 160 billion!
The deal was good, and Luo Cheng was very satisfied. This time, Chengtian Private Equity Fund made a profit of 60%, 60 billion!

It can be said that he has made a lot of money, earning so much money.

(End of this chapter)